Thus, the role of tumor necrosis factor-α (TNF-α) and interleukin-1 (IL-1) in the development of EGFR inhibitor-associated skin rash was shown and a possible therapeutic role for anti-TNF agents was suggested [35]. Here, EGFR is linked to Skin rash.